miR-337-3p and its targets STAT3 and RAP1A modulate paclitaxel sensitivity in non-small cell lung cancers (NSCLCs)

被引：1
|
作者：
Du, Liqin [1 ]
Subauste, Maria C. [1 ]
Baker, Michael [1 ]
DeSeyo, Christopher [1 ]
Borkowski, Robert [1 ]
Zhong, Shihua [1 ]
Schageman, Jeoffrey J. [1 ]
Greer, Rachel [1 ]
Yang, Chin-Rang [1 ]
Girard, Luc [1 ]
Gazdar, Adi F. [1 ]
Wistuba, Ignacio I. [2 ]
Minna, John D. [1 ]
Pertsemlidis, Alexander [1 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4709
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4709
引用
收藏
页数：2
相关论文
共 50 条
  • [41] miR-124 Modulates Gefitinib Resistance through SNAI2 and STAT3 in Non-small Cell Lung Cancer
    胡发涌
    曹小年
    徐沁孜
    邓豫
    来森艳
    马静
    胡俊波
    Current Medical Science, 2016, 36 (06) : 839 - 845
  • [42] Cucurbitacin B enhances apoptosis in gefitinib resistant non-small cell lung cancer by modulating the miR-17-5p/STAT3 axis
    Yu, Baodan
    Zheng, Lixia
    Tang, Huiqin
    Wang, Weixin
    Lin, Yongping
    MOLECULAR MEDICINE REPORTS, 2021, 24 (04)
  • [43] LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway
    Ma, Jianqun
    Cao, Kui
    Ling, Xiaodong
    Zhang, Ping
    Zhu, Jinhong
    CANCERS, 2022, 14 (12)
  • [44] Curcumin inhibits human non-small cell lung cancer xenografts by targeting STAT3 pathway
    Xu, Xiaofang
    Zhu, Yuping
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (08): : 3633 - 3641
  • [45] Regulation of non-small cell lung cancer stem cells by STAT3 and WNT pathways.
    Shao, Chunli
    DeSevo, Chris
    Girard, Luc
    Yenerall, Paul
    Behrens, Carmen
    Wistuba, Ignacio
    Minna, John D.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [46] STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non-Small Cell Lung Cancer
    Njatcha, Christian
    Farooqui, Mariya
    Kornberg, Adam
    Johnson, Daniel E.
    Grandis, Jennifer R.
    Siegfried, Jill M.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 1917 - 1926
  • [47] Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities
    Parakh, Sagun
    Ernst, Matthias
    Poh, Ashleigh R.
    CANCERS, 2021, 13 (24)
  • [48] STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
    Attili, Ilaria
    Karachaliou, Niki
    Bonanno, Laura
    Berenguer, Jordi
    Bracht, Jillian
    Codony-Servat, Jordi
    Codony-Servat, Carles
    Ito, Masaoki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [49] IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer
    Guo, Jianping
    Kim, Donghwa
    Kurtyka, Courtney
    Chen, Huihua
    Wu, Danwei
    Mittal, Aman
    Cheng, Jin Q.
    CANCER RESEARCH, 2012, 72
  • [50] META-ANALYSIS OF STAT3 AND P-STAT3 EXPRESSION AND SURVIVAL IN NON-SMALL-CELL LUNG CANCER
    Xu, Yunhua
    Gu, Linping
    Cheng, Baijun
    Lu, Shun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S783 - S783
12345